Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024

Rhea-AI Summary

• English
• French
• German
• Italian
• Korean
• Spanish

Insmed Incorporated (INSM) will host a conference call on May 9, 2024, to discuss its first-quarter 2024 financial results. Shareholders and interested parties can participate in the call to receive a business update.

BRIDGEWATER, N.J., April 25, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its first-quarter 2024 financial results on Thursday, May 9, 2024.

Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, May 9, 2024, to discuss the financial results and provide a business update.

Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7862189. The call will also be webcast live on the Company's website at www.insmed.com.

A replay of the conference call will be accessible approximately 1 hour after its completion through June 8, 2024, by dialing (800) 770-2030 (U.S.) and (609) 800-9909 (international) and referencing access code 7862189. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is also advancing an early-stage research engine encompassing a wide range of technologies and modalities, including artificial intelligence-driven protein engineering, gene therapy, and protein manufacturing. Insmed is headquartered in Bridgewater, New Jersey, with additional offices and research locations throughout the United States, Europe, and Japan. Visit www.insmed.com to learn more.

Contact:

Investors:

Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-first-quarter-2024-financial-results-conference-call-on-thursday-may-9-2024-302126577.html

SOURCE Insmed Incorporated

FAQ

When will Insmed host a conference call to discuss its first-quarter 2024 financial results?

Insmed will host the conference call on Thursday, May 9, 2024.

How can investors participate in the conference call?

Investors can participate by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) and referencing access code 7862189.

Where can the conference call be webcasted live?

The conference call will be webcast live on Insmed's website at www.insmed.com.

How long will the replay of the conference call be accessible?

The replay will be accessible for approximately 1 hour after its completion through June 8, 2024.

Where can the archived webcast of the call be found?

The archived webcast will be available for 90 days under the Investor Relations section of Insmed's website at www.insmed.com.